{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:20:38Z","timestamp":1791235238029,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"P\ufb01zer"},{"DOI":"10.13039\/100002491","name":"Bristol-Meyers Squibb","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cerenis"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Esperion, Resverlogix"},{"name":"Sano\ufb01 Regeneron"},{"DOI":"10.13039\/100015237","name":"Medicines Company","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jvascsurg.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jvs.2018.07.027","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T11:05:03Z","timestamp":1540206303000},"page":"1595-1606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Medical and lifestyle management of peripheral arterial disease"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3514-3971","authenticated-orcid":false,"given":"Saman L.","family":"Parvar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fitridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2018.07.027_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.tvir.2016.04.001","article-title":"Epidemiology of peripheral arterial disease and critical limb ischemia","volume":"19","author":"Dua","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"issue":"Suppl S","key":"10.1016\/j.jvs.2018.07.027_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.07.027_bib3","first-page":"e726","article-title":"2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.07.027_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejvs.2017.07.018","article-title":"2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"55","author":"Aboyans","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2018.07.027_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2018.07.027_bib6","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/j.atherosclerosis.2008.10.023","article-title":"Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry","volume":"204","author":"Cacoub","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2018.07.027_bib7","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jvs.2004.08.049","article-title":"Influence of smoking on incidence and prevalence of peripheral arterial disease","volume":"40","author":"Willigendael","year":"2004","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.07.027_bib8","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jvs.2014.08.064","article-title":"Smoking cessation is associated with decreased mortality and improved amputation-free survival among patients with symptomatic peripheral artery disease","volume":"60","author":"Armstrong","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.07.027_bib9","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jvs.2013.12.011","article-title":"Preoperative smoking is associated with early graft failure after infrainguinal bypass surgery","volume":"59","author":"Selvarajah","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"issue":"Suppl","key":"10.1016\/j.jvs.2018.07.027_bib10","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1002\/bjs.1800691309","article-title":"The measured effect of stopping smoking on intermittent claudication","volume":"69","author":"Quick","year":"1982","journal-title":"Br J Surg"},{"key":"10.1016\/j.jvs.2018.07.027_bib11","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2010.07.031","article-title":"Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial","volume":"56","author":"Hennrikus","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2018.07.027_bib12","first-page":"CD000146","article-title":"Nicotine replacement therapy for smoking cessation","volume":"11","author":"Stead","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2018.07.027_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","article-title":"Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial","volume":"121","author":"Rigotti","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.07.027_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.mayocp.2014.12.016","article-title":"Effect of physical activity assessment on prognostication for peripheral artery disease and mortality","volume":"90","author":"Chang","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jvs.2018.07.027_bib15","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jvs.2012.04.046","article-title":"Supervised walking therapy in patients with intermittent claudication","volume":"56","author":"Fakhry","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.07.027_bib16","first-page":"CD005263","article-title":"Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication","volume":"8","author":"Fokkenrood","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2018.07.027_bib17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2014.12.043","article-title":"Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study","volume":"65","author":"Murphy","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2018.07.027_bib18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s40279-016-0635-5","article-title":"Combined lower limb revascularisation and supervised exercise training for patients with peripheral arterial disease: a systematic review of randomised controlled trials","volume":"47","author":"Meneses","year":"2016","journal-title":"Sports Med"},{"key":"10.1016\/j.jvs.2018.07.027_bib19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jvs.2014.08.070","article-title":"Safety of supervised exercise therapy in patients with intermittent claudication","volume":"61","author":"Gommans","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.07.027_bib20","first-page":"1","volume":"38","author":"de la Haye","year":"1992","journal-title":"Vasa Suppl"},{"key":"10.1016\/j.jvs.2018.07.027_bib21","first-page":"CD009638","article-title":"Modes of exercise training for intermittent claudication","volume":"7","author":"Lauret","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2018.07.027_bib22","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.114.011990","article-title":"Therapy for peripheral artery disease: gaps in treating patients with claudication","volume":"130","author":"Mays","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.07.027_bib23","doi-asserted-by":"crossref","first-page":"e001107","DOI":"10.1161\/JAHA.114.001107","article-title":"Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial","volume":"3","author":"Gardner","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2018.07.027_bib24","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.2009.623","article-title":"Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials","volume":"301","author":"Berger","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2018.07.027_bib25","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A\u00a0randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2018.07.027_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehn534","article-title":"Patients with peripheral arterial disease in the CHARISMA trial","volume":"30","author":"Cacoub","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2018.07.027_bib27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1583\/13-4275MR.1","article-title":"Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease","volume":"20","author":"Strobl","year":"2013","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2018.07.027_bib28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jvs.2010.04.027","article-title":"Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial","volume":"52","author":"Belch","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.07.027_bib29","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.07.027_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus clopidogrel in symptomatic peripheral artery disease","volume":"376","author":"Hiatt","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.07.027_bib31","first-page":"CD001999","article-title":"Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication","volume":"5","author":"Cosmi","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2018.07.027_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa065959","article-title":"Oral anticoagulant and antiplatelet therapy and peripheral arterial disease","volume":"357","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.07.027_bib33","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(99)07199-8","article-title":"Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2018.07.027_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.07.027_bib35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2018.07.027_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mayocp.2015.09.021","article-title":"CHADS2 scores as a predictor of ischemic stroke in patients with peripheral artery disease","volume":"91","author":"Yang","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jvs.2018.07.027_bib37","first-page":"1","article-title":"A\u00a0nationwide cohort study of the role of CHADS2 score in predicting lower extremity amputation and death among patients with peripheral arterial occlusive disease","volume":"26","author":"Hu","year":"2018","journal-title":"Aging Male"},{"key":"10.1016\/j.jvs.2018.07.027_bib38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1526602815574687","article-title":"A\u00a0review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin after femoropopliteal endovascular intervention","volume":"22","author":"Tangelder","year":"2015","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2018.07.027_bib40","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2018.07.027_bib41","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(14)62070-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data","volume":"384","author":"Sundstrom","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2018.07.027_bib42","first-page":"145","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.07.027_bib43","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","volume":"358","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.07.027_bib44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.atherosclerosis.2013.09.037","article-title":"Meta-analysis of angiotensin converting enzyme inhibitors effect on walking ability and ankle brachial pressure index in patients with intermittent claudication","volume":"231","author":"Shahin","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2018.07.027_bib45","first-page":"CD005508","article-title":"Beta blockers for peripheral arterial disease","volume":"9","author":"Paravastu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2018.07.027_bib46","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jvs.2018.07.027_bib47","first-page":"CD003075","article-title":"Treatment of hypertension in peripheral arterial disease","volume":"12","author":"Lane","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2018.07.027_bib48","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1681\/ASN.2005080827","article-title":"Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease","volume":"17","author":"Mui","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jvs.2018.07.027_bib49","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2011.01.008","volume":"57","author":"Aronow","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2018.07.027_bib50","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.07.027_bib51","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.07.027_bib52","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/HJH.0b013e3283469976","article-title":"Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients","volume":"29","author":"Reboldi","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jvs.2018.07.027_bib53","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.07.027_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40292-017-0185-4","article-title":"Management of hypertension in the elderly and frail elderly","volume":"24","author":"Ferri","year":"2017","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.jvs.2018.07.027_bib55","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","article-title":"Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions","volume":"45","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.07.027_bib56","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","article-title":"Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry","volume":"35","author":"Kumbhani","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2018.07.027_bib57","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170\u2008000 participants in 26 randomised trials","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2018.07.027_bib58","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0002-9149(03)00833-6","article-title":"Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment","volume":"92","author":"Aronow","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvs.2018.07.027_bib59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(03)00010-X","article-title":"Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease","volume":"114","author":"Mondillo","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.jvs.2018.07.027_bib60","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2017.07.745","article-title":"2017 Focused update of the 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk","volume":"70","author":"Lloyd-Jones","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2018.07.027_bib61","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.07.027_bib62","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2018.07.027_bib63","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2337\/diacare.25.5.894","article-title":"UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes","volume":"25","author":"Adler","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jvs.2018.07.027_bib64","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2337\/diacare.26.12.3333","article-title":"Peripheral arterial disease in people with diabetes","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jvs.2018.07.027_bib65","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/1358863X14538330","article-title":"Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty","volume":"19","author":"Singh","year":"2014","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2018.07.027_bib66","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.2337\/dc10-0939","article-title":"The influence of glycemic control on the prognosis of Japanese patients undergoing percutaneous transluminal angioplasty for critical limb ischemia","volume":"33","author":"Takahara","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jvs.2018.07.027_bib67","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","article-title":"Intensive glucose control and macrovascular outcomes in type 2 diabetes","volume":"52","author":"Turnbull","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jvs.2018.07.027_bib68","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","article-title":"Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials","volume":"5","author":"Zoungas","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jvs.2018.07.027_bib69","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jamda.2012.04.012","article-title":"Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes","volume":"13","author":"Sinclair","year":"2012","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jvs.2018.07.027_bib70","first-page":"948","article-title":"Hypoglycemia in patients with diabetes and renal disease","volume":"4","author":"Alsahli","year":"2015","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jvs.2018.07.027_bib71","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.07.027_bib72","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.117.032031","article-title":"Cardiovascular outcomes and safety of empagliflozin in patients with type 2 diabetes mellitus and peripheral artery disease: a subanalysis of EMPA-REG OUTCOME","volume":"137","author":"Verma","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.07.027_bib73","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1479164114525548","article-title":"ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD\u2014summary","volume":"11","author":"Ryden","year":"2014","journal-title":"Diab Vasc Dis Res"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521418318044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521418318044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T12:10:15Z","timestamp":1662293415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521418318044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0741521418318044"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2018.07.027","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical and lifestyle management of peripheral arterial disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2018.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}